NetraMark
Healthcare Software · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1655 Dupont St Ste 101, Toronto, Ontario...Phone Number
(403) 681-2549Website
www.netramark.comRevenue
<$5 MillionStock Symbol
AIAIIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About NetraMark
NetraMark specializes in advanced AI solutions designed to enhance clinical trial development processes. Their flagship product, NetraAI, utilizes innovative technology to provide insights into patient populations, optimizing study design and improving trial efficacy. The company also offers solutions like NetraPlacebo and NetraGPT, which leverage data to understand placebo responses and enhance explainability, respectively. Target clients include clinical trial professionals and sponsors looking to improve trial outcomes through data-driven insights.Explore more
NetraMark Org Chart
SK
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NetraMark your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on NetraMark recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if NetraMark has recently received funding, and reach out quickly before it becomes old news!
Click to see if NetraMark had a recent Job posting/layoffs
Check out if NetraMark is spiking on competitors!
Product Launch: Get notified when NetraMark launches new products
Funding: Get notified immidiatlly once NetraMark has new funding data
Congratulate Masked Content for being promoted to Masked Content at NetraMark
NetraMark, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined NetraMark as Masked Content
Find 3 more new buyers
Compare Similar Companies to NetraMark
Compare insights from companies similar to NetraMark, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NetraMark is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
NetraMark is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about NetraMark.
NetraMark financials insights
Gather financial insights about NetraMark, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$2.5M
NetraMark Tech Stack
A closer look at the technologies used by NetraMark
See more technologies
Most Recent Scoops
Project
NetraMark has published a study on arXiv comparing NetraAI against large language models including ChatGPT and DeepSeek, demonstrating that large language models are unsuitable for clinical trial variable analysis due to combinatorial limitations, while NetraAI's proprietary mathematical paradigm is designed specifically for this application.
Artificial Intelligence, Clinical Operations
Project
NetraMark has been qualified by the FDA to participate in the Model-Informed Drug Development program, with the FDA explicitly distinguishing NetraAI from traditional AI, machine learning, large language models, and Bayesian statistical models, which are disqualified from the program.
Machine Learning, Artificial Intelligence
Lateral Move
Executive Move
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
NetraMark News & Media
NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner
TORONTO, July 09, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a company developing advanced artificial intelligence solutions for clinical trial optimization and precision medicine, today announced that it signed a new contract to analyze a phase 2 neurodegeneration dataset through its established contract research organization (CRO) partnership.NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company
TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that it has signed a new agreement with a biopharmaceutical company developing a late-stage central nervous system therapy.NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026
TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET.NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting
Company to participate in plenary panel on artificial intelligence in psychiatry and present two scientific posters highlighting explainable AI applications in precision psychiatry Company to participate in plenary panel on artificial intelligence in psychiatry and present two scientific posters highlighting explainable AI applications in precision psychiatry
Read more news
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding NetraMark
Sign Up For FreeTo access detailed company insights
NetraMark specializes in advanced AI solutions designed to enhance clinical trial development processes. Their flagship product, NetraAI, utilizes innovative technology to provide insights into patient populations, optimizing study design and improving trial efficacy. The company also offers solutions like NetraPlacebo and NetraGPT, which leverage... Read More
